« Back
Home /
Nolatrexed

Nolatrexed

Item no.	TMO-T4228-200mg
Manufacturer	TargetMol
CASRN	147149-76-6
Amount	200 mg
Quantity options	100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 1 mg 200 mg 25 mg 2 mg 500 mg 50 mg 5 mg
Category	Oncology Metabolism Cholesterol & Lipid Metabolism Enzymes Other Fatty Acid Enzymes Reagents & Chemicals Molecules By Organ Head & Neck Cancer
Type	Molecules
Specific against	other
Citations	1: Zheng J, et al. Metastatic nasopharyngeal carcinoma outcomes in patients on cisplatin with nolatrexed or 5-fluorouracil. Oncol Res Treat. 2014;37(10):540-4. doi: 10.1159/000368107. Epub 2014 Sep 16. PubMed PMID: 25342504.
Smiles	S(C1=C2C(=CC=C1C)NC(N)=NC2=O)C=3C=CN=CC3
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	DNA/RNA Synthesis inhibitor
Shipping Condition	Cool pack
Available
Manufacturer - Targets	DNA/RNA Synthesis
Shipping Temperature	Cool pack
Storage Conditions	-20
Molecular Weight	284.34
Description	Nolatrexed is a thymidylate synthase inhibitor with potential anticancer activity.
Pathways	DNA Damage/DNA Repair\|\|\|Cell Cycle/Checkpoint
Bioactivity	Nolatrexed, also known as AG337, is a thymidylate synthase inhibitor with potential anticancer activity.
Receptor	Thymidylate synthase

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T4228-200mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 200 mg

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question